The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells

Hui Lyu(University of Colorado Anschutz Medical Campus), Bolin Liu(Huazhong University of Science and Technology)
Oncotarget
November 26, 2015
Cited by 24


Related Papers